First human trial of Buprenorphine depot injection for the maintenance treatment of opioid dependence and chronic pain
Phase of Trial: Phase I/II
Latest Information Update: 15 May 2017
At a glance
- Drugs Buprenorphine (Primary)
- Indications Pain
- Focus Adverse reactions; First in man; Pharmacokinetics; Therapeutic Use
- 15 May 2017 According to BioDelivery Sciences media release, results from the first dosing cohort expected to be available in the fourth quarter
- 17 Mar 2017 Results from the first dosing cohort are expected to be available in the third quarter of 2017, according to a BioDelivery Sciences media release.
- 09 Nov 2016 According to BioDelivery Sciences media release, the company expects to submit the IND application before the end of 2016 and expects to initiate the trial in the first quarter of 2017.